All articles tagged with #direct to consumer
Rivian Automotive secured a major victory in Washington by obtaining the right to sell vehicles directly to consumers, challenging traditional dealership franchise laws and potentially signaling a broader shift in how electric vehicles are marketed and sold in the United States.
An BI writer frames Kempczinski’s Instagram posts about the Big Arch as part of a broader ‘going direct’ PR trend, notes the viral backlash over his tiny bite, and shares trying the burger herself (it's tasty); the piece argues the posts may be aimed more at McDonald's employees and franchisees than the general public, illustrating a shifting corporate communications strategy.
President Trump unveiled TrumpRx, a direct-to-consumer site offering discounts on about 40 branded medicines from five major drugmakers with GoodRx backing; experts say savings may be muted for many since insurance plans and deductibles often yield lower costs, and pricing details remain unclear. The administration touts it as transformative, but critics warn it could curb competition and that broader Medicare drug-price negotiations would be more effective. A potential Express Scripts agreement could expand coverage if the regulatory environment allows, signaling that Congress may need to act to count purchases toward deductibles.
The White House announced TrumpRx, a direct-to-consumer hub that directs cash-paying patients to discounts offered by drugmakers on their own sites, as part of efforts to lower U.S. prescription costs. The site does not sell drugs itself and may not benefit insured patients who rely on coverage, but could help uninsured or underinsured access drugs not widely covered, such as obesity medications; participating makers include Lilly and Novo Nordisk, with prices advertised (e.g., Ozempic and Wegovy at about $350/month) amid broader debated savings, since actual prices often depend on rebates and payer contracts. The overall impact on out-of-pocket costs remains uncertain.
Eli Lilly and Walmart have partnered to offer Zepbound, a weight loss drug, at discounted prices through retail locations and home delivery, expanding access and competing with rivals like Novo Nordisk amid regulatory and market pressures.
President Trump announced a deal with Pfizer to sell drugs directly to consumers at discounted prices through a new website, TrumpRx.gov, aiming to align U.S. drug prices with those in other developed countries. The initiative includes Pfizer's commitment to offer new drugs at the same price globally and to provide drugs to Medicaid at most-favored-nation prices, though the impact on average consumers and Medicaid beneficiaries remains uncertain. The website is expected to launch in 2026, but critics suggest the measure may be more symbolic than transformative.
President Trump announced the upcoming launch of 'TrumpRx,' a website aimed at allowing Americans to buy prescription drugs directly at discounted prices, with the site expected to be available in early 2026. This initiative follows Pfizer's agreement to lower drug prices for U.S. consumers and aligns with broader efforts to reduce pharmaceutical costs through new pricing strategies and manufacturing investments.
President Trump is set to announce the launch of 'TrumpRx', a website for discounted drugs, and a deal with Pfizer to lower medication costs, amid ongoing efforts to reduce drug prices in the US through policies like the 'Most Favored Nation' rule and direct-to-consumer sales channels, despite industry opposition and legal challenges.
President Trump announced plans to crack down on pharmaceutical advertising, aiming to address concerns over overmedicalization of children and the influence of direct-to-consumer drug ads, which have increased prescriptions and raised health risks. The move seeks to strengthen FDA oversight, especially on social media, to ensure more balanced and responsible drug marketing.
ESPN and Fox have launched new streaming services that bundle live sports rights with innovative features, aiming to simplify access for fans and reduce costs, marking a significant shift in the sports media landscape.
ESPN's new all-in-one streaming service aims to provide broad access to sports content but may result in a net loss of subscribers overall, according to CNBC Sport.
ESPN has launched its long-anticipated direct-to-consumer streaming app, integrating ESPN+ and its linear networks, with a focus on engagement and personalized experiences, priced at $30/month, and aiming to work seamlessly with traditional pay-TV providers and distributors.
Selling drugs directly to consumers by pharmaceutical companies is unlikely to significantly lower drug costs for patients, as cash prices are higher than insurance prices and direct purchases do not contribute to insurance deductibles or out-of-pocket limits.
Novo Nordisk now offers Ozempic for $499 a month for cash-paying patients through its direct-to-consumer pharmacy and partnerships, aiming to make the costly diabetes drug more accessible amid ongoing debates over drug prices in the US.
Levi Strauss stock soared 17.5% after beating first-quarter earnings estimates and raising its yearly guidance, despite an 8% revenue decline due to one-time events. The company's shift to direct-to-consumer sales boosted gross margin and reduced inventories, while adjusted earnings per share exceeded expectations. Levi Strauss maintained its revenue guidance for the year and raised its adjusted EPS forecast, signaling a successful turnaround strategy amidst industry struggles. However, investors are advised to temper their expectations given the stock's significant gains.